Literature DB >> 24945431

ABO blood group and von Willebrand factor: biological implications.

Massimo Franchini, Silvia Crestani, Francesco Frattini, Cinzia Sissa, Carlo Bonfanti.   

Abstract

ABO blood group antigens are complex carbohydrate molecules expressed on the surface of red blood cells and a variety of human cells and tissues. It is well known that ABO blood type exerts a profound influence on hemostasis, being a major determinant of von Willebrand factor (VWF), and consequently factor VIII, plasma levels. In this review, we will focus on the molecular mechanisms underlying the interaction between ABO blood group and VWF in normal and pathological conditions.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24945431     DOI： 10.1515/cclm-2014-0564

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


  22 in total

1.  Blood group distribution and life-expectancy: a single-centre experience.

Authors:  Carlo Mengoli; Carlo Bonfanti; Chiara Rossi; Massimo Franchini
Journal:  Blood Transfus       Date:  2014-10-29       Impact factor: 3.443

2.  ABO blood groups and the risk of retinal vein occlusion.

Authors:  Elisabetta Borella; Luca Spiezia; Giacomo Turatti; Anna Poretto; Michelangelo Marobin; Elena Campello; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2021-01-04       Impact factor: 3.397

3.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

4.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

Review 5.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

Review 6.  Towards personalised therapy for von Willebrand disease: a future role for recombinant products.

Authors:  Emmanuel J Favaloro
Journal:  Blood Transfus       Date:  2016-03-22       Impact factor: 3.443

7.  The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

Authors:  Enrico Capuzzo; Carlo Bonfanti; Francesco Frattini; Paolo Montorsi; Rosalia Turdo; Maria Grazia Previdi; Elisa Turrini; Massimo Franchini
Journal:  Ann Transl Med       Date:  2016-05

Review 8.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

9.  ABO blood group and neurodegenerative disorders: more than a casual association.

Authors:  Massimo Franchini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-11-23       Impact factor: 3.443

10.  Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.

Authors:  Georgios Gitas; Louisa Proppe; Ibrahim Alkatout; Dimitrios Tsolakidis; Achim Rody; Christos Kotanidis; Sascha Baum
Journal:  Blood Transfus       Date:  2020-06-04       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.